These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33312353)

  • 1. Assessment of hazard immune-related genes and tumor immune infiltrations in renal cell carcinoma.
    Chen H; Xie J; Jin P
    Am J Transl Res; 2020; 12(11):7096-7113. PubMed ID: 33312353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of the immune-related signature and immune infiltration analysis for breast ductal and lobular carcinoma.
    Zhang B; Wang Q; Fu C; Jiang C; Ma S
    Ann Transl Med; 2019 Dec; 7(23):730. PubMed ID: 32042746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma.
    Zhang C; Li Z; Qi F; Hu X; Luo J
    Ann Transl Med; 2019 Nov; 7(22):648. PubMed ID: 31930049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in bladder urothelial carcinoma.
    Zhang C; Shen L; Qi F; Wang J; Luo J
    J Cell Physiol; 2020 Apr; 235(4):3849-3863. PubMed ID: 31596511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma.
    Jiang F; Wu C; Wang M; Wei K; Zhou G; Wang J
    Clin Chim Acta; 2020 Dec; 511():306-318. PubMed ID: 33164879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Metabolism-Related Genes and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
    Li H; Mo Z
    Int J Gen Med; 2021; 14():6885-6898. PubMed ID: 34703293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Role of Tumor Mutation Burden Combined With Immune Infiltrates in Skin Cutaneous Melanoma Based on Multi-Omics Analysis.
    Yan J; Wu X; Yu J; Zhu Y; Cang S
    Front Oncol; 2020; 10():570654. PubMed ID: 33240814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic alternative splicing signature reveals the landscape of immune infiltration in Pancreatic Cancer.
    Wang L; Bi J; Li X; Wei M; He M; Zhao L
    J Cancer; 2020; 11(22):6530-6544. PubMed ID: 33046974
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma.
    Ghatalia P; Gordetsky J; Kuo F; Dulaimi E; Cai KQ; Devarajan K; Bae S; Naik G; Chan TA; Uzzo R; Hakimi AA; Sonpavde G; Plimack E
    J Immunother Cancer; 2019 May; 7(1):139. PubMed ID: 31138299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma.
    Zhang J; Yan A; Cao W; Shi H; Cao K; Liu X
    Cancer Cell Int; 2020 Dec; 20(1):584. PubMed ID: 33372609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis-Related Molecular Subtypes and a Novel Prognostic Signature in Clear Cell Renal Cell Carcinoma Patients.
    Li H; Chen L; Ke ZB; Chen SH; Xue XY; Zheng QS; Wei Y; Zeng K; Xu N
    Int J Gen Med; 2021; 14():6325-6342. PubMed ID: 34629897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Three Core Secretome Genes Associated with Immune Infiltration in High Tumor Mutation Burden Across 14 Major Solid Tumors.
    Wu H; Wang H; Jiang Z; Chen Y
    Int J Gen Med; 2021; 14():6755-6767. PubMed ID: 34703282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTLA4 has a profound impact on the landscape of tumor-infiltrating lymphocytes with a high prognosis value in clear cell renal cell carcinoma (ccRCC).
    Liu S; Wang F; Tan W; Zhang L; Dai F; Wang Y; Fan Y; Yuan M; Yang D; Zheng Y; Deng Z; Liu Y; Cheng Y
    Cancer Cell Int; 2020; 20():519. PubMed ID: 33117084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of an immune prognostic classifier for clear cell renal cell carcinoma.
    Gu YY; Chen G; Lin P; Cheng JW; Huang ZG; Luo J; Zhai GQ; Wang YL; Yan HB; Li SH
    Cancer Biomark; 2020; 27(2):265-275. PubMed ID: 31929144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Analysis of the Relationships Between Tumor Mutation Burden With Immune Infiltrates in Cervical Cell Carcinoma.
    Zhou C; Li C; Peng S; Zhou L; Li H
    Front Mol Biosci; 2020; 7():582911. PubMed ID: 33134320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Genomic Characterization of Tumor Microenvironment and Relevant Signature in Clear Cell Renal Cell Carcinoma.
    Zhang C; Qi F; Zheng Y; Xia X; Li X; Wang X
    Front Oncol; 2022; 12():749119. PubMed ID: 35651807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma Based on Multi-Omics Analysis.
    Yin L; Zhou L; Xu R
    Front Mol Biosci; 2020; 7():599142. PubMed ID: 33681288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
    Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
    Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
    Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.